Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2023-11-16 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
2023年第一次职工大会决议公告
Board/Management Information Classification · 95% confidence The document is a company announcement regarding the results of a staff meeting held on November 15, 2023, where an employee representative was elected as a supervisor. It includes details about the meeting notice, attendance, voting results, and compliance with company law and articles of association. There is no financial data, no mention of annual or interim reports, no audit information, no earnings release, no capital or financing updates, and no regulatory certifications. The document is a formal announcement of a board/management related decision (election of a staff representative to the supervisory board). This fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. Therefore, the classification is MANG with high confidence.
2023-11-16 Chinese
2023年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 78% confidence The document is a legal opinion letter issued by a law firm on the legality of convening and holding a 2023 second Extraordinary General Meeting of shareholders. It includes detailed vote counts, percentages, and the resolution passed at that meeting. According to the category definitions, the specific category for official vote results from a general meeting is Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-11-16 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure of the company's information disclosure management system, including rules and procedures for periodic reports (annual, interim, quarterly), temporary reports, board and shareholder meeting resolutions, transaction disclosures, related party transactions, and other significant events. It references regulatory requirements from the China Securities Regulatory Commission and Beijing Stock Exchange, and outlines the company's obligations for timely, accurate, and complete disclosure of material information. The document is lengthy (15,000 characters) and contains comprehensive policy and procedural content rather than a specific financial report or announcement. It does not present financial statements, earnings data, or audit opinions, nor is it a transcript, presentation, or voting result. It is a governance and compliance document detailing internal rules and governance practices related to information disclosure. Therefore, the most appropriate classification is Governance Information (CGR).
2023-11-16 Chinese
独立董事候选人声明与承诺（曹翠萍）
Board/Management Information Classification · 95% confidence The document is a formal announcement by an individual named Cao Cuiping regarding her qualifications and independence as a candidate for an independent director position on the board of Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes detailed statements about compliance with legal and regulatory requirements for independent directors, declarations of no conflicts of interest, and commitments to fulfill the role responsibly. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically the nomination and qualifications of a board member candidate. The document length is 3251 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2023-11-16 Chinese
独立董事候选人声明与承诺（任勇）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an individual named Ren Yong regarding his qualifications and independence as a candidate for an independent director position at Jiangsu Senxuan Pharmaceutical Co., Ltd. It includes detailed statements about compliance with legal and regulatory requirements for independent directors, personal qualifications, and commitments to fulfill the role responsibly. There is no financial data, no report or results, no meeting materials, no voting results, no legal proceedings, no capital changes, or other financial or corporate event disclosures. The document is essentially an official announcement related to board/management information, specifically the nomination and qualification declaration of a board member candidate. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3249 characters, which is consistent with a detailed announcement rather than a full report.
2023-11-16 Chinese
独立董事提名人声明与承诺（沈小燕）
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors of Jiangsu Senxuan Pharmaceutical Co., Ltd. nominating an independent director candidate. It details the qualifications, independence criteria, and compliance with relevant laws and regulations for the nominee. There is no financial data, no report attached or referenced as published, and no mention of voting results or meeting materials. The content is about board/management information specifically related to director nomination and qualifications. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short (3119 characters), consistent with an announcement rather than a full report.
2023-11-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.